In vivo dynamics of pulmonary lymphoid cell subpopulations generated against pulmonary metastasis: evaluation by broncho alveolar lavage fluid

[1]  M. J. Ehrke,et al.  Modification of host antitumor defense mechanisms in mice by progressively growing tumor. , 1989, Cancer research.

[2]  P. Hokland,et al.  Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. , 1988, Journal of the National Cancer Institute.

[3]  M. Taniguchi,et al.  Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes. , 1988, Cancer research.

[4]  W. Roggendorf,et al.  Inflammatory infiltrates and natural killer cell presence in human brain tumors , 1988, Cancer.

[5]  J. Johnson,et al.  Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. , 1987, Cancer research.

[6]  D. Elder,et al.  Natural killer cells in the host response to melanoma. , 1987, Cancer research.

[7]  M. Mokyr,et al.  Interplay between the toxic effects of anticancer drugs and host antitumor immunity in cancer therapy. , 1987, Cancer investigation.

[8]  I. Bruderman,et al.  Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. , 1987, Cancer research.

[9]  O. Matsubara,et al.  Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia. , 1986, Cancer research.

[10]  J. Finlay-Jones,et al.  In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas. , 1985, British Journal of Cancer.

[11]  I. Bursuker,et al.  Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells , 1984, The Journal of experimental medicine.

[12]  M. Mokyr,et al.  Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide. , 1983, Cancer research.

[13]  R. North,et al.  Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells , 1983, The Journal of experimental medicine.

[14]  J. Hopkins,et al.  Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro. , 1982, British Journal of Cancer.

[15]  N. Hanna.  Inhibition of experimental tumor metastasis by selective activation of natural killer cells. , 1982, Cancer research.

[16]  I. Fidler,et al.  Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[18]  S. Segal,et al.  Differences in cell surface antigens of tumor metastases and those of the local tumor. , 1979, Journal of the National Cancer Institute.

[19]  V. Schirrmacher,et al.  Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes , 1979, International journal of cancer.

[20]  A. Mantovani,et al.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes , 1979, International journal of cancer.

[21]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.